The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
Abstract Inflammation is a natural defense process of the innate immune system, associated with the release of proinflammatory cytokines such as interleukin-1β, interleukin-6, interleukin-12 and TNFα; and enzymes including iNOS through the activation and nuclear translocation of NF-κB p65 due to the...
Main Authors: | Khalid N. M. Abdelazeem, M. Zaher Kalo, Sandra Beer-Hammer, Florian Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-86514-6 |
Similar Items
-
Therapeutic efficacy of gut microbiota-derived polyphenol metabolite Urolithin A
by: Shilpa S. Shetty, et al.
Published: (2024-03-01) -
Urolithins: The Colon Microbiota Metabolites as Endocrine Modulators: Prospects and Perspectives
by: Ravindran Vini, et al.
Published: (2022-02-01) -
Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases
by: Kailin Li, et al.
Published: (2022-06-01) -
P850: THE EFFECT OF UROLITHIN PRODUCTION BY GUT MICROBIOTA IN MULTIPLE MYELOMA
by: Alba Rodríguez-García, et al.
Published: (2023-08-01) -
Urolithins: The Gut Based Polyphenol Metabolites of Ellagitannins in Cancer Prevention, a Review
by: Sami A. Al-Harbi, et al.
Published: (2021-06-01)